EUVIMEDEUVIMED entdecken
Open Access

Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability

Adam J Sugarman, Luong Do Huynh, Aidin Shabro, Antonio Di Cristofano

Cancer Letters · 2023-08 · 568 · 216304

DOI: 10.1016/j.canlet.2023.216304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023-08. Verfasst von Adam J Sugarman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, USA. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaplastic thyroid cancer (ATC) is one of the most aggressive and lethal tumor types, characterized by loss of differentiation, epithelial-to-mesenchymal transition, extremely high proliferation rate, and generalized resistance to therapy. To identify novel relevant, targetable molecular alterations, we analyzed gene expression profiles from a genetically engineered ATC mouse model and from human patient datasets, and found consistent upregulation of genes encoding enzymes involved in the one-carbon metabolic pathway, which uses serine and folates to generate both nucleotides and glycine. Genetic and pharmacological inhibition of SHMT2, a key enzyme of the mitochondrial arm of the one-carbon pathway, rendered ATC cells glycine auxotroph and led to significant inhibition of cell proliferation and colony forming ability, which was primarily caused by depletion of the purine pool. Notably, these growth-suppressive effects were significantly amplified when cells were grown in the presence of physiological types and levels of folates. Genetic depletion of SHMT2 dramatically impaired tumor growth in vivo, both in xenograft models and in an immunocompetent allograft model of ATC. Together, these data establish the upregulation of the one-carbon metabolic pathway as a novel and targetable vulnerability of ATC cells, which can be exploited for therapeutic purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsAnimalsMiceHumansCell Line, TumorCell ProliferationGlycinePurines

Stichwörter der Autor:innen

Folate metabolismGlycineThyroid cancerXenograft

Substanzen

GlycinePurines

Autor:innen und Institutionen

  • Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: antonio.dicristofano@einsteinmed.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Sugarman, A. J., Huynh, L. D., Shabro, A., & Di Cristofano, A. (2023). Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability. Cancer Letters, 568, 216304. https://doi.org/10.1016/j.canlet.2023.216304

Vancouver

Sugarman AJ, Huynh LD, Shabro A, Di Cristofano A. Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability. Cancer Letters. 2023;568:216304. doi:10.1016/j.canlet.2023.216304

BibTeX
@article{Sugarman2023,
  author = {Sugarman, Adam J and Huynh, Luong Do and Shabro, Aidin and Di Cristofano, Antonio},
  title = {Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability},
  journal = {Cancer Letters},
  year = {2023},
  volume = {568},
  pages = {216304},
  doi = {10.1016/j.canlet.2023.216304}
}
Kostenlos starten →